ライフサイエンスコーパス: choline acetyltransferase

1 me in the production of acetylcholine (i.e., choline acetyltransferase).

2 uronal markers neurofilament 200 (NF200) and choline acetyltransferase.

3 d simultaneously for tyrosine hydroxylase or choline acetyltransferase.

4 of the neurotransmitter-synthesizing enzyme choline acetyltransferase.

5 ns were OFQ-IR, all OFQ-IR neurons expressed choline acetyltransferase.

6 mesopontine tegmental area colocalizing with choline acetyltransferase.

7 se structures in some neurons that stain for choline acetyltransferase.

8 75 and trkA, and with the cholinergic marker choline acetyltransferase.

9 cells expressing FLI were immunopositive for choline acetyltransferase.

10 s only 13% of m2-stained neurons colocalized choline acetyltransferase.

11 munoreactivity for nitric oxide synthase and choline acetyltransferase.

12 enteric plexus of the ileum expressed IR for choline acetyltransferase (56.9%), substance P (55.0%),

13 nological and histological stains, including choline acetyltransferase, acetylcholinesterase, tyrosin

14 n examined two cholinergic synaptic markers, choline acetyltransferase activity (ChAT) and [3H]hemich

15 Choline acetyltransferase activity (ChAT) and [3H]hemich

16 Choline acetyltransferase activity (ChAT) was assessed w

17 de recognized VIP-binding sites and enhanced choline acetyltransferase activity as well as cognitive

18 Reduction of precuneus choline acetyltransferase activity co-occurs with greate

19 ds of mice lacking one or both genes contain choline acetyltransferase activity comparable to that of

20 NGF maximally increased choline acetyltransferase activity in all cortical regio

21 duced a significant reduction in hippocampal choline acetyltransferase activity in all tested groups

22 his mild effect covaried with an increase in choline acetyltransferase activity in neocortex.

23 opsied brain showed a pronounced decrease in choline acetyltransferase activity in the frontal and te

24 triatum of AChE-/- mice showed no changes in choline acetyltransferase activity or levels of the vesi

25 In longitudinal muscle, choline acetyltransferase activity was lower in patients

26 Choline acetyltransferase activity was reduced in the im

27 There were no significant changes in choline acetyltransferase activity, or in muscarinic M1

28 Furthermore, the expression of choline acetyltransferase, an ACh synthase, was reduced

29 central nervous system cholinergic indices--choline acetyltransferase and acetylcholinesterase activ

30 The activity of choline acetyltransferase and acetylcholinesterase in 9

31 and a significant decrease in expression of choline acetyltransferase and calretinin, demonstrating

32 Presently, such maps are unavailable for choline acetyltransferase and carnitine acetyltransferas

33 ating normal prefrontal immunoreactivity for choline acetyltransferase and dopamine beta-hydroxylase.

34 The cholinergic markers choline acetyltransferase and hemicholinium-3 binding, a

35 Recent crystallography studies of choline acetyltransferase and homology structural models

36 hese bundles contained acetylcholinesterase, choline acetyltransferase and nerve growth factor recept

37 cholinergic neurons as manifested by loss of choline acetyltransferase and p75NGFR immunoreactivity.

38 Changes in rabbit retinal choline acetyltransferase and parvalbumin immunoreactivi

39 ls were induced to become neurons expressing choline acetyltransferase and substance P and formed neu

40 motoneurons and interneurons that expressed choline acetyltransferase and substance P, and in inhibi

41 ssion of the cholinergic gene locus encoding choline acetyltransferase and the vesicular acetylcholin

42 stochemical experiments, using antibodies to choline acetyltransferase and vesicular acetylcholine tr

43 ted cholinergic gene locus, we now show that choline acetyltransferase and vesicular acetylcholine tr

44 terneurons and projection neurons containing choline acetyltransferase and/or NADPH diaphorase were s

45 uorescence staining using antibodies against choline-acetyltransferase and neurofilament was performe

46 cytochemistry for dopamine beta-hydroxylase, choline acetyltransferase, and serotonin in the primate

47 noreactivity was coexpressed with calbindin, choline acetyltransferase, and substance P in the myente

48 contained relatively dense staining for TH, choline acetyltransferase, and substance P, whereas vaso

49 3, alpha5, alpha7, and beta2 nAChR subunits, choline acetyltransferase, and the asymmetric and globul

50 ncluding calbindin, calretinin, parvalbumin, choline acetyltransferase, and tyrosine hydroxylase.

51 Choline acetyltransferase assays of frontal and occipita

52 unoreactive for cholecystokinin precursor or choline acetyltransferase, because both types of amacrin

53 dGs were usually negative for glycine, ChAT (choline acetyltransferase), bNOS (brain-type nitric oxid

54 in induced dendritic degeneration, decreased choline acetyltransferase but increased nitric oxide syn

55 jecting neurons were immunoreactive (IR) for choline acetyltransferase but not nitric oxide synthase

56 also found to be clearly immunoreactive for choline acetyltransferase by this age.

57 detection of NOS with tyrosine hydroxylase, choline acetyltransferase, calbindin, calretinin, and se

58 acrine cell markers gamma-aminobutyric acid, choline acetyltransferase, calretinin, or tyrosine hydro

59 and expression of alpha-smooth muscle actin, choline acetyltransferase, CD45, glial fibrillary acidic

60 ACh) using a temperature-sensitive allele of choline acetyltransferase (Cha(ts2)).

61 alretinin-IR, 5-HT-accumulating, and ON-type choline acetyltransferase (ChAT) ACs in wild-type and Ch

62 sease (AD), loss of cortical and hippocampal choline acetyltransferase (ChAT) activity has been corre

63 ne-p75-SAP produced a dose-dependent loss of choline acetyltransferase (ChAT) activity in the hippoca

64 of 192Sap produced 50 and 80% depletions of choline acetyltransferase (ChAT) activity in the neocort

65 nths of age we observed a 40-50% decrease in choline acetyltransferase (ChAT) activity in two of thre

66 Choline acetyltransferase (ChAT) activity served as a me

67 tration of NGF on P4 or later induced septal choline acetyltransferase (ChAT) activity to the same re

68 physin-immunoreactive presynaptic terminals, choline acetyltransferase (ChAT) activity, and ChAT-posi

69 Microdialyzed acetylcholine (ACh), choline acetyltransferase (ChAT) activity, and the rate

70 ture osteoblast cell line, MC3T3-E1, induced choline acetyltransferase (ChAT) activity.

71 inal ganglion cell layer (GCL) and measuring choline acetyltransferase (ChAT) activity.

72 We measured two cholinergic markers, choline acetyltransferase (ChAT) and acetylcholinesteras

73 Choline acetyltransferase (ChAT) and acetylcholinesteras

74 f 5 days, alterations in the localisation of choline acetyltransferase (ChAT) and calretinin immunore

75 Light microscopic analyses revealed that choline acetyltransferase (ChAT) and GABA immunoreactive

76 In this study, cells that coexpress choline acetyltransferase (ChAT) and GABA or glutamic ac

77 Choline acetyltransferase (ChAT) and glutamic acid decar

78 etinogram (ERG), the retinal localization of choline acetyltransferase (ChAT) and neuronal nitric oxi

79 TrkA tyrosine phosphorylation in the septum, choline acetyltransferase (ChAT) and p75 neurotrophin re

80 splanted cells developed immunoreactivity to choline acetyltransferase (ChAT) and sent axons into the

81 procedures using antibodies directed against choline acetyltransferase (ChAT) and the dopamine D5 rec

82 , p75-positive (p75+) cells were enriched in choline acetyltransferase (ChAT) and the high-affinity c

83 ated by immunohistochemical visualization of choline acetyltransferase (ChAT) and the low-affinity ne

84 Immunocytochemistry for choline acetyltransferase (ChAT) and the vesicular acety

85 Choline acetyltransferase (ChAT) and the vesicular ACh t

86 fects of one week of estrogen replacement on choline acetyltransferase (ChAT) and trkA mRNA expressio

87 Immunohistochemical markers for choline acetyltransferase (ChAT) and tyrosine hyroxylase

88 Third, we correlated levels of freezing with choline acetyltransferase (ChAT) and vesicular acetylcho

89 NF stimulates mRNA and protein expression of choline acetyltransferase (ChAT) and vesicular acetylcho

90 acing of nigral efferents with pre-embedding choline acetyltransferase (ChAT) and/or glutamate (Glu)

91 We studied the expression of choline acetyltransferase (ChAT) by immunocytochemistry

92 sion of the critical neurotransmitter enzyme choline acetyltransferase (ChAT) by in vitro motor neuro

93 In eukaryotes, choline acetyltransferase (ChAT) catalyzes the reversibl

94 ncurrent staining for the cholinergic marker choline acetyltransferase (ChAT) demonstrated that virtu

95 Conversely, m2/choline acetyltransferase (ChAT) double labeling reveale

96 , abnormally ubiquitinated proteins, reduced choline acetyltransferase (ChAT) enzyme expression, frag

97 The expression of the choline acetyltransferase (ChAT) enzyme that synthesizes

98 g (CPG) circuit, we studied mice lacking the choline acetyltransferase (ChAT) enzyme.

99 ping septum that increases ACh synthesis and choline acetyltransferase (Chat) gene expression both in

100 both induce GAL gene expression and inhibit choline acetyltransferase (ChAT) gene expression in this

101 cent microspheres was combined with nNOS and choline acetyltransferase (ChAT) immunocytochemistry, an

102 xidase (WGA-HRP) combined with glutamate and choline acetyltransferase (ChAT) immunohistochemical and

103 ex by using retrograde tracing combined with choline acetyltransferase (ChAT) immunohistochemistry in

104 olinergic amacrine cells were identified via choline acetyltransferase (ChAT) immunohistochemistry.

105 s Q140 males at 1 and 4 months of age, using choline acetyltransferase (ChAT) immunolabeling to ident

106 sed stereological estimates of the number of choline acetyltransferase (ChAT) immunopositive neurons

107 Fos immunoreactivity (Fos-ir), choline acetyltransferase (ChAT) immunoreactivity and re

108 Moreover, the choline acetyltransferase (ChAT) immunoreactivity associ

109 PACAP- and choline acetyltransferase (ChAT) immunoreactivity were c

110 ew intrinsic CARTp-IR neurons also exhibited choline acetyltransferase (ChAT) immunoreactivity, indic

111 Intrinsic NOS-IR cardiac neurons exhibited choline acetyltransferase (ChAT) immunoreactivity, indic

112 50% of muOR-immunoreactive neurons contained choline acetyltransferase (ChAT) immunoreactivity, where

113 by examining the OBs of adult zebrafish for choline acetyltransferase (ChAT) immunoreactivity.

114 (VLDB) revealed enhanced optical density for choline acetyltransferase (ChAT) in both young and aged

115 tochemical staining for this peptide and for choline acetyltransferase (ChAT) in macaque monkeys, in

116 ed axons and interneurons immunoreactive for choline acetyltransferase (ChAT) in regions of the execu

117 Immunohistochemistry 14 d after MI revealed choline acetyltransferase (ChAT) in stellate sympathetic

118 edium spiny neurons (MSNs) and D2-expressing choline acetyltransferase (ChAT) interneurons express Sl

119 liest ray-finned fishes, the distribution of choline acetyltransferase (ChAT) is described in Polypte

120 Here, we show that choline acetyltransferase (ChAT) is expressed and ACh is

121 lls could be considered cholinergic based on choline acetyltransferase (ChAT) mRNA expression.

122 erneurons were identified by the presence of choline acetyltransferase (ChAT) mRNA.

123 the labeled neurons in IF5 were found to be choline acetyltransferase (ChAT) negative, indicating th

124 tions were stained immunohistochemically for choline acetyltransferase (ChAT) or p140trk (trk) or his

125 brains were sectioned and immunolabeled for choline acetyltransferase (ChAT) or p75-neurotrophin rec

126 Because interneurons containing choline acetyltransferase (ChAT) or vasoactive intestina

127 in-2 (ChR2) protein under the control of the choline acetyltransferase (ChAT) promoter (ChAT-ChR2-EYF

128 Choline acetyltransferase (ChAT) protein was expressed i

129 enzyme glutamic acid decarboxylase (GAD) and choline acetyltransferase (ChAT) revealed that all CG ne

130 An antibody directed against choline acetyltransferase (ChAT) revealed that ChAT-like

131 d s3 and positioned between the two bands of choline acetyltransferase (ChAT) staining.

132 Choline acetyltransferase (ChAT) synthesizes acetylcholi

133 ibody raised against the biosynthetic enzyme choline acetyltransferase (ChAT) was applied to individu

134 Within the superior olive, choline acetyltransferase (ChAT) was expressed different

135 ), neuronal nitric oxide synthase (nNOS), or choline acetyltransferase (ChAT) were performed in whole

136 dentified a previously unknown population of choline acetyltransferase (ChAT)(+) neurons residing in

137 %-60% decrease of both parvalbumin (PV)+ and choline acetyltransferase (ChAT)+ cholinergic interneuro

138 ties, cortical projections and expression of choline acetyltransferase (ChAT), a synthetic enzyme for

139 f the cholinergic system in the hippocampus: choline acetyltransferase (ChAT), acetylcholinesterase (

140 end stage/140 days were analyzed for p75NTR, choline acetyltransferase (ChAT), activating transcripti

141 ightly fixed rabbit retinas with antisera to choline acetyltransferase (ChAT), AMPA receptor subunits

142 , aspartate, gamma-aminobutyric acid (GABA), choline acetyltransferase (ChAT), and a N-methyl-D-aspar

143 dic protein (GFAP), microglial marker F4/80, choline acetyltransferase (ChAT), and syntaxin 1.

144 The effects of a potent inhibitor of choline acetyltransferase (ChAT), BW813U, on timing beha

145 We used immunohistochemistry of choline acetyltransferase (ChAT), calbindin, calretinin,

146 ctors including acetylcholinesterase (AChE), choline acetyltransferase (ChAT), choline transporter 1

147 nergic because of their immunoreactivity for choline acetyltransferase (ChAT), contradictory findings

148 to identify GABA and Fos protein, as well as choline acetyltransferase (ChAT), in histological sectio

149 of a known estrogen-responsive gene product, choline acetyltransferase (ChAT), in the hippocampus and

150 plex synergistically recruits another enzyme choline acetyltransferase (ChAT), leading to enhanced se

151 ) by establishing and analyzing mice lacking choline acetyltransferase (ChAT), the biosynthetic enzym

152 been reported to potentiate the activity of choline acetyltransferase (ChAT), the enzyme that produc

153 Choline acetyltransferase (ChAT), the enzyme that synthe

154 In this study, cells that expressed choline acetyltransferase (ChAT), the enzyme that synthe

155 onditional mutant in which the gene encoding choline acetyltransferase (ChAT), the sole synthetic enz

156 Antibodies directed against choline acetyltransferase (ChAT), the synthesizing enzym

157 By 10 d, saporin eliminated staining for choline acetyltransferase (ChAT), the synthetic enzyme f

158 unoreactivity was also compared with that of choline acetyltransferase (ChAT), tyrosine hydroxylase (

159 on of several specialized enzymes, including choline acetyltransferase (ChAT), vesicular acetylcholin

160 vasoactive intestinal polypeptide (VIP), and choline acetyltransferase (ChAT), was used to characteri

161 l mouse model of the ACh-synthesizing enzyme choline acetyltransferase (Chat), we report that local e

162 howed that CD4(+) T lymphocytes that express choline acetyltransferase (ChAT), which catalyzes the sy

163 istribution of nitric oxide synthase (NOS)-, choline acetyltransferase (ChAT)-, and vasoactive intest

164 ial septum containing hippocampal-projecting choline acetyltransferase (ChAT)-, neuronal nitric oxide

165 s estrogen replacement prevented the loss of choline acetyltransferase (ChAT)-containing cells in the

166 ssion of the tdTomato fluorescent protein in choline acetyltransferase (ChAT)-expressing cells were u

167 Choline acetyltransferase (ChAT)-immunolabeled cells wer

168 The number, size, and staining intensity of choline acetyltransferase (ChAT)-immunopositive cells in

169 d adjacent VTA contain moderate to intensely choline acetyltransferase (ChAT)-immunopositive neurons.

170 Seven days after AF64A administration choline acetyltransferase (ChAT)-immunoreactive fibers w

171 riments showed that these bipolar cells were choline acetyltransferase (ChAT)-immunoreactive.

172 GABA-like and choline acetyltransferase (ChAT)-like immunoreactivity w

173 y vulnerable to glaucomatous damage, whereas choline acetyltransferase (ChAT)-positive and glycinergi

174 n individuals under age 65 years, 72% of the choline acetyltransferase (ChAT)-positive BFCN contained

175 In the graft area, choline acetyltransferase (ChAT)-positive fibers express

176 as measured by increased c-Fos expression in choline acetyltransferase (ChAT)-positive interneurons.

177 oyed 43% of Nissl-stained neurons and 70% of choline acetyltransferase (ChAT)-positive neurons 5 days

178 led significant decrease in the soma size of choline acetyltransferase (ChAT)-positive neurons in the

179 ither vesicular acetylcholine transporter or choline acetyltransferase (ChAT).

180 h) is specifically synthesized by the enzyme choline acetyltransferase (ChAT).

181 antibodies to tyrosine hydroxylase (TH) and choline acetyltransferase (ChAT).

182 calbindin-D(28k), and parvalbumin as well as choline acetyltransferase (ChAT).

183 , glutamate decarboxylases (gad1, gad2), and choline acetyltransferase (chat).

184 urons were identified using antisera against choline acetyltransferase (ChAT).

185 d method with a polyclonal antiserum against choline acetyltransferase (ChAT).

186 immunohistochemistry with antibodies against choline acetyltransferase (ChAT).

187 inputs from Tm9 and Tm2, which both express choline acetyltransferase (ChAT).

188 ntisera to different isoforms of GnRH and to choline acetyltransferase (ChAT).

189 ne and acetyl CoA by the enzymatic action of choline acetyltransferase (ChAT).

190 Multiple tyrosine hydroxylase (Th)::Cre and choline acetyltransferase (Chat)::Cre lines were produce

191 By the expression of fluorescent proteins in choline acetyltransferase (ChAT)::Cre(+) transgenic rats

192 The activity of choline acetyltransferase (ChAT, the enzyme that carries

193 onjugates and a polyclonal antiserum against choline acetyltransferase (ChAT; Chemicon Ab 143), that

194 Choline acetyltransferase (ChAT; EC ) catalyzes the reve

195 composed of two distinct genetic functions: choline acetyltransferase (ChAT; EC 2.3.1.6), the enzyme

196 rkA receptor) but not others (e.g., cortical choline acetyltransferase [ChAT] activity, the number of

197 m control ganglia and explanted ganglia were choline acetyltransferase(ChAT)-immunoreactive, indicati

198 ring of cholinergic interneurons (expressing choline acetyltransferase; ChAT) and GABAergic interneur

199 l image analysis of localising antibodies to choline acetyltransferase, co-localised with protein gen

200 linergic signaling, including a reduction in choline acetyltransferase enzymatic activity and the num

201 Choline acetyltransferase enzyme activity, protein level

202 ns expressing parvalbumin or somatostatin or choline acetyltransferase exhibited varying degrees of e

203 cholinergic forebrain neurons, we activated choline acetyltransferase expressing neurons using chann

204 Choline acetyltransferase-expressing interneurones (ChAT

205 -day differences in acetylcholinesterase and choline acetyltransferase expression and general neurona

206 te that the normal developmental increase of choline acetyltransferase expression becomes critically

207 ated and nonphosphorylated neurofilament and choline acetyltransferase expression were comparable bet

208 movement and death, and reduce transport of choline acetyltransferase from cell bodies to the synaps

209 ysis of temperature-sensitive mutants in the choline acetyltransferase gene revealed that the sprouti

210 cular acetylcholine transporter gene and the choline acetyltransferase gene, was investigated in PC12

211 expression of tyrosine hydroxylases 1 and 2, choline acetyltransferase, histidine decarboxylase, or o

212 Second, AMNs were counted in double-stained choline acetyltransferase immunocytochemical and NADPH d

213 h we did not visualize colocalization of m2+/choline acetyltransferase-immunonegative neurons and the

214 bel immunohistochemistry to demonstrate that choline acetyltransferase-immunopositive fibers in the S

215 A sparse plexus of choline acetyltransferase-immunoreactive (ChAT) fibres w

216 nducted quantitative comparative analyses of choline acetyltransferase-immunoreactive axons in cortic

217 correlated significantly with the number of choline acetyltransferase-immunoreactive cells in the NB

218 ealed a few dystrophic neurites and neurons, choline acetyltransferase-immunoreactive fibers were not

219 Virtually all choline acetyltransferase-immunoreactive myenteric neuro

220 Approximately 65% of striatal choline acetyltransferase-immunoreactive neurons express

221 A high percentage (89%) of striatal choline acetyltransferase-immunoreactive neurons were do

222 s clearly defined by peptidergic markers and choline acetyltransferase immunoreactivity.

223 ocytin and characterized for the presence of choline acetyltransferase immunoreactivity.

224 We found that upregulated translation of choline acetyltransferase in the CPEB2 KO dorsal motor n

225 eover, neurons double-labeled with c-Fos and choline acetyltransferase in the NAmb were identified in

226 lum (p < 0.005, one-way ANOVA) and for ChAT (choline acetyltransferase) in the male vagal lobe and th

227 alpha 7 nicotinic acetylcholine receptor and choline acetyltransferase, in A beta 42-burdened, activa

228 or the axonal transport of a soluble enzyme, choline acetyltransferase, in a specific subset of neuro

229 ry for temporal information are sensitive to choline acetyltransferase inhibition in rats.

230 aced-starburst amacrine cells (identified by choline acetyltransferase-IR) but in less than 50% of th

231 revealed that m2 was detected in only 14% of choline acetyltransferase-labeled neurons, whereas only

232 Cell counts demonstrated that 90% of choline acetyltransferase-labeled striatal neurons expre

233 Choline acetyltransferase levels were significantly corr

234 s of ACh associated with increased levels of choline acetyltransferase mRNA and decreased cholinester

235 c neurons as cells in both sites coexpressed choline acetyltransferase mRNA.

236 th antibodies against the CB(1) receptor and choline acetyltransferase, neurofilament proteins, calbi

237 sin (eNpHR), or channelrhodopsin-2 (ChR2) in Choline acetyltransferase neurons (ChAT(+)) or Arch in L

238 Choline acetyltransferase neurons in the vertical diagon

239 din DK28, calretinin, nitric oxide synthase, choline-acetyltransferase, neuropeptide Y, serotonin, ne

240 oviruses targeted to atrial ganglia enhanced choline acetyltransferase-nNOS co-localization (P < 0.05

241 etween the autistic and comparison groups in choline acetyltransferase or acetylcholinesterase activi

242 ity of choline had any effect on hippocampal choline acetyltransferase or acetylcholinesterase activi

243 orated with vehicle, or with dsRNA targeting choline acetyltransferase or axonin-1, did not exhibit t

244 affold by mapping neurons immunopositive for choline acetyltransferase or retrogradely labeled from c

245 ed pulp macrophages, but they do not express choline acetyltransferase or vesicular acetylcholine tra

246 de (nitric oxide synthase) or acetylcholine (choline acetyltransferase) or in situ hybridization for

247 into the median raphe (MR) and parvalbumin, choline acetyltransferase, or calretinin as well as doub

248 urons that expressed calbindin, substance P, choline acetyltransferase, or neuropeptide Y.

249 e-expressing, but not acetylcholinesterase-, choline acetyltransferase-, or tryptophan hydroxylase-ex

250 controls: median percentage surface area of choline acetyltransferase over PGP was 17.5% (range 10.0

251 on of eGFP in intrinsic cholinergic neurons (choline acetyltransferase positive) and intrinsic adrene

252 number of cells was 197 +/- 23, and 92% were choline acetyltransferase positive, implying a cholinerg

253 All chambers of the heart were innervated by choline acetyltransferase-positive axons, implying choli

254 t decrease in the numbers of motoneurons and choline acetyltransferase-positive boutons.

255 eurotrophin receptor (p75(NTR))-positive and choline acetyltransferase-positive cells in this region

256 Choline acetyltransferase-positive cells of Area X do no

257 ly higher number (10-15% increase) of septal choline acetyltransferase-positive cells than the vehicl

258 of this nAChR subtype reduces the number of choline acetyltransferase-positive cells, macrophages, a

259 revented Abeta-induced apoptosis and loss of choline acetyltransferase-positive cholinergic neurons.

260 sic neurones, all of which co-localized with choline acetyltransferase-positive ganglia.

261 der basal conditions, pERK is upregulated in choline acetyltransferase-positive interneurons in DKO m

262 Choline acetyltransferase-positive neurons in the pedunc

263 Choline acetyltransferase-positive neurons were Fluorogo

264 hs the numbers of pedunculopontine tegmentum choline acetyltransferase-positive neurons were reduced

265 sferase enzymatic activity and the number of choline acetyltransferase-positive neurons, as well as,

266 In GAD67-GFP knock-in mice, BF cholinergic (choline acetyltransferase-positive) neurons were intermi

267 ic mice expressing cre-recombinase under the choline acetyltransferase promoter were used to selectiv

268 ressing Cre recombinase under control of the choline acetyltransferase promoter.

269 S1/CHGFP mice and reversed the reductions in choline acetyltransferase protein levels in the hippocam

270 cetylcholine receptor, acetylcholinesterase, choline acetyltransferase, rapsyn, MuSK and Na(v)1.4.

271 ns and fewer than 2% of neuropeptide Y (NPY)/choline acetyltransferase secretomotor neurons, and P2Y2

272 combined with peroxidase immunostaining for choline acetyltransferase showed that 60% of all synapti

273 burst amacrine cells with antibodies against choline acetyltransferase showed that the CD15-positive

274 GFP-positive efferents that co-expressed choline acetyltransferase specifically terminated in the

275 f the m2-labeled neurons, whereas only 6% of choline acetyltransferase-stained perikarya were dual la

276 of neuronal function as indicated by reduced choline acetyltransferase staining (R(2) = 0.91).

277 d cells were reacted with antibodies against choline acetyltransferase, substance P and the neurokini

278 t five different vesicular proteins (UNC-17, choline acetyltransferase, Synaptotagmin, Synaptobrevin,

279 A mutant choline acetyltransferase that incorporates four amino a

280 These included the localisation of Thy-1 and choline acetyltransferase, the a- and b-wave amplitudes

281 lethanolamine N-methyltransferase (PNMT) and choline acetyltransferase, the synthesizing enzymes for

282 in the density of fibers immunoreactive for choline acetyltransferase, this same treatment markedly

283 protein alignment data, was used to redesign choline acetyltransferase to accommodate L-carnitine as

284 In this study, we used an immunolabeling for choline acetyltransferase to demonstrate, for the first

285 The cells were also double-labelled for choline acetyltransferase to determine if they were cont

286 perior salivatory nucleus, or for PRV-Ba and choline acetyltransferase to establish the neurochemical

287 mRNA combined with immunohistochemistry for choline acetyltransferase to reveal cholinergic neurons.

288 The presynaptic cholinergic enzyme, choline acetyltransferase, together with nicotinic and m

289 Nearly all cells expressing choline acetyltransferase, trkA or glutamic acid decarbo

290 hoprotein, calretinin, acetylcholinesterase, choline acetyltransferase, tyrosine hydroxylase, calbind

291 tylated tubulin, human neuronal protein C/D, choline acetyltransferase, tyrosine hydroxylase, neurona

292 , and human neuronal protein C/D, as well as choline acetyltransferase, tyrosine hydroxylase, nitric

293 TRPC6-IR fibers were not immunoreactive for choline acetyltransferase, tyrosine hydroxylase, or subs

294 Within the nucleus basalis, choline acetyltransferase was found in 35% of the m2-lab

295 In circular muscle, activity of choline acetyltransferase was lower in patients with div

296 ine was synthesized in yolk sacs, but 70 kDa choline acetyltransferase was undetectable by immunoblot

297 5-HT(2A) receptors and choline acetyltransferase were localized by immunocytoch

298 id decarboxylase, glycine transporter-2, and choline acetyltransferase were used as markers for GABAe

299 he concurrent visualization of tauopathy and choline acetyltransferase were used to determine if the

300 e C, parvalbumin, calbindin, calretinin, and choline acetyltransferase were used to stain different r